MAM
SRNE

McCarthy Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

McCarthy Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-375
Closed -$1K – 332
2022
Q1 		$1K Hold
375
– – ﹤0.01% 330
2021
Q4 		$2K Hold
375
– – ﹤0.01% 306
2021
Q3 		$3K Hold
375
– – ﹤0.01% 262
2021
Q2 		$4K Hold
375
– – ﹤0.01% 277
2021
Q1 		$3K Hold
375
– – ﹤0.01% 274
2020
Q4 		$3K Buy
+375
New +$3.01K ﹤0.01% 251

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return